Voluntary Recall of five (5) lots of APO-QUETIAPINE XR (quetiapine fumarate extended-release tablets)
Jan 31, 2025
January 30, 2025
Apotex Inc. ("Apotex"), in coordination with the Regulatory Operations and Enforcement Branch (ROEB) of Health Canada, is initiating a voluntary TYPE I recall to the Pharmacy Level for five (5) lots of "APO-QUETIAPINE XR (quetiapine fumarate extended-release tablets)".
Learn more